你即將離開本站

並前往https://pubmed.ncbi.nlm.nih.gov/35075146/

KRAS(G12D) can be targeted by potent inhibitors via ...

KRAS mutation occurs in nearly 30% of human cancers, yet the most prevalent and oncogenic KRAS(G12D) variant still lacks inhibitors. Herein, we ...

確定！ 回上一頁

查詢 「KRAS G12D」的人也找了：

  1. KRAS G12D inhibitor
    2.
  2. kras基因
    3.
  3. Sotorasib
    4.
  4. kras是什麼
    5.
  5. KRAS G12C
    6.
  6. KRAS mutation
    7.
  7. KRAS G12D lung cancer
    8.
  8. kras突變
    9.